Since MDM4 forms a heterodimer with MDM2 and promotes MDM2‐mediated polyubiquitination and subsequent degradation of p53, we investigated potential interactions/synergistic effects between MDM4 SNP34091 and MDM2 SNPs with respect to cancer risk. The gene discussed is TP53; the disease is cancer.